 - A vaccine not foreseen by the study protocol administered during the period starting from 30 days before each dose of vaccine and ending 30 days after, with the exception of inactivated influenza vaccine and other vaccines given as a part of the nationalregional immunisation schedule, that are allowed at any time during the study period. 